Human Beta-Amyloid (1-42)
Supplier: Anaspec Inc
Beta-Amyloid (1-42) peptide, a major component of amyloid plaques, accumulates in neurons of Alzheimer’s disease brains. Biochemical analysis of the amyloid peptides isolated from Alzheimer’s disease brain indicates that Beta-Amyloid (1-42) is the principal species associated with senile plaque amyloids, while Beta-Amyloid (1-40) is more abundant in cerebrovascular amyloid deposit.
Sequence: DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA
Molecular Weight: 4514.1 Da
% Peak Area by HPLC: ≥95
Peptide Content: ≥ 60%
Storage condition: -20°C
Lee, HJ., et al. (2016). Effects of hydroxyl group variations on a flavonoid backbone toward modulation of metal-free and metal-induced amyloid-β aggregation Inorg. Chem. Front.,3 381
Citations:
Derrick, J., et al. (2016). Importance of the dimethylamino functionality on a multifunctional framework for regulating metals, Amyloid-β, and oxidative stress in Alzheimer’s Disease Inorg. Chem. doi: 10.1021/acs.inorgchem.6b00525
Lee, HJ., et al. (2016). Effects of hydroxyl group variations on a flavonoid backbone toward modulation of metal-free and metal-induced amyloid-β aggregation Inorg. Chem. Front.,3 381
Mandler, M. et al. (2015). Tailoring the antibody response to aggregated Aß using novel Alzheimer-Vaccines PLoS One doi:10.1371/journal.pone.0115237.
Mandler, M. et al. (2015). Tailoring the antibody response to aggregated Aß using novel Alzheimer-Vaccines PLoS One doi:10.1371/journal.pone.0115237.
Learn more
About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...